Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Base de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Neuroimage Clin ; 24: 102020, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31734534

RESUMEN

Treatment with interferon (IFN) has been associated with depressive side effects. Previous neuroimaging studies have provided information about changes in brain activation patterns in patients under treatment with IFN-alpha, but the effect of other IFNs, or the role of the underlying disease, has yet to be clarified. In the present fMRI study, we looked at brain changes after 8 days of IFN-beta treatment in N = =17 healthy volunteers, thus avoiding the possible confound of the effects of underlying pathology in studies of IFN-treated patients with neurological or other medical disorders. We followed a symptom dimensional approach by simultaneously investigating two distinct symptom domains of depressiveness: negative affect (amygdala) and appetitive motivation (ventral striatum). In these early phases of IFN treatment we detected a selective change in neural substrates of appetitive motivation, consistent with the predominant symptomatic change recorded in psychopathology ratings. In contrast, the fMRI phenotype of negative affect, which is known to characterize disorders of affect involving anxiety and depressiveness as well as individual vulnerability to depression, was unchanged after treatment. These findings suggest that IFN may induce an affective syndrome through a mechanism involving down-regulation of appetitive motivation.


Asunto(s)
Afecto , Amígdala del Cerebelo , Ansiedad , Depresión , Factores Inmunológicos/farmacología , Interferón beta/farmacología , Motivación , Recompensa , Estriado Ventral , Adolescente , Adulto , Afecto/efectos de los fármacos , Afecto/fisiología , Anciano , Amígdala del Cerebelo/diagnóstico por imagen , Amígdala del Cerebelo/efectos de los fármacos , Amígdala del Cerebelo/fisiología , Ansiedad/inducido químicamente , Ansiedad/diagnóstico por imagen , Ansiedad/fisiopatología , Depresión/inducido químicamente , Depresión/diagnóstico por imagen , Depresión/fisiopatología , Expresión Facial , Reconocimiento Facial/efectos de los fármacos , Reconocimiento Facial/fisiología , Femenino , Humanos , Factores Inmunológicos/efectos adversos , Interferón beta/efectos adversos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Motivación/efectos de los fármacos , Motivación/fisiología , Estriado Ventral/diagnóstico por imagen , Estriado Ventral/efectos de los fármacos , Estriado Ventral/fisiología , Adulto Joven
2.
PLoS One ; 13(6): e0198244, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29864139

RESUMEN

Functional imaging studies of affective disorders have demonstrated abnormal activity in the amygdala in response to emotionally salient stimuli. Since in other studies this response has been shown to habituate during the scanning session, it is not clear if it may be of use in monitoring disease progression or remission, or in monitoring the effects of therapy, as habituation may confound normalisation of response. We investigated here amygdala activation in healthy participants exposed to displays of emotional facial expressions in a sample of N = 31 individuals assessed twice in an interval of three weeks. At this interval no habituation could be detected, suggesting the validity of this imaging assay in repeated assessments of amygdalar reactivity. However, the fusiform gyrus and the inferior frontal lobes showed decreases in activations that may be related to the role of these areas in encoding visual and emotional aspects of the stimuli.


Asunto(s)
Amígdala del Cerebelo , Emociones/fisiología , Cara , Imagen por Resonancia Magnética , Percepción Visual/fisiología , Adulto , Amígdala del Cerebelo/diagnóstico por imagen , Amígdala del Cerebelo/fisiología , Femenino , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA